Cara Therapeutics

-$0.04 (-0.30%) Today

+$0.01 (+0.07%) As of 8:02 PM UTC after-hours

Why Robinhood?

You can buy or sell CARA and other stocks, options, and ETFs commission-free!

About CARA

Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).

CEO

Derek T. Chalmers

Employees

Headquarters

Stamford, Connecticut

Founded

2004

CARA Key Statistics

Market Cap

651.51M

Price-Earnings Ratio

56.63

Dividend Yield

—

Average Volume

1.25M

High Today

$13.63

Low Today

$13.33

Open Price

$13.40

Volume

381.76K

52 Week High

$29.65

52 Week Low

$11.80

Analyst Ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

CARA Earnings

-$0.74

$0.04

$0.81

$1.59

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.59 per share

Actual

-$0.47 per share

Replay Earnings Call